Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
TAORMINA is an international, multicentre, randomised phase 3 trial for patients with oligometastatic breast cancer (OMBC) that will be allocated to combined stereotactic ablative radiotherapy (SABR) + systemic therapy (investigational arm) versus systemic therapy alone (control arm) as 1st line therapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rak piersi z ograniczoną liczbą przerzutów.
- •Pacjenci w wieku 18 lat lub starsi.
- •1 do 5 przerzutów w maksymalnie dwóch różnych miejscach w ciele.
- •Pacjentki, które już rozpoczęły leczenie ogólne, mogą wziąć udział, jeśli choroba jest stabilna.
- •Stan ogólny pacjentki dobry (nie jest zbyt osłabiona chorobą).
✗ Disqualifies
- •Pacjentki, które otrzymały więcej niż jedno leczenie ogólne w związku z rozsianym rakiem piersi.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 21, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (19)
Cork University Hospital
Cork, Ireland
Bon Secours Cork In Partnership with UPMC Hillman Cancer Centre
Cork, Ireland
St Luke's Radiation Oncology Network (SLRON) at St Luke's Hospital Dublin, St James Hospital Dublin and Beaumont Hospital Dublin
Dublin, Ireland
University Hospital Galway (UHG)
Galway, Ireland
Sheba Medical Center Institute of Oncology
Tel Aviv, Israel
Azienda Ospedaliero - Universitaria Careggi
Florence, Italy
Humanitas Cancer Centre
Milan, Italy
Istituto Nationale Tumori (INT)
Milan, Italy
Haukeland University Hospital
Bergen, Norway
Oslo University Hospital, Radiumhospitalet
Oslo, Norway
Universitetssykehuset Nord-Norge
Tromsø, Norway
St. Olavs Hospital
Trondheim, Norway
Institute of Oncology Ljubljana
Ljubljana, Slovenia
Ryhov County Hospital
Jönköping, Sweden
Skånes University Hospital
Malmö, Sweden
Karolinska University Hospital
Stockholm, Sweden
Norrlands University Hospital
Umeå, Sweden
Örebro University Hospital
Örebro, Sweden
Sahlgrenska University Hospital
Gothenburg, Sweden
Trial contact
Katarzyna Kulbacka-Ortiz, CTO
Annika Baan
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.